Category: Research

Second Survey: PSP Psoriatic Arthritis

The British Psoriatic Arthritis Consortium is working with the James Lind Alliance to run a priority setting partnership (PSP),
looking to create a national ‘top 10’ list of research priorities for psoriatic arthritis.

Survey 2 – What questions would you like to see answered by #PsoriaticArthritis research?

Following the first PSP survey in June 2020, the process moves to identifying the questions that are the most important to people who live and work with psoriatic arthritis.

This is a unique opportunity for you to have your say in psoriatic arthritis research.…

Read more of this article

LJMU chronic pain experiences survey

Researchers at Liverpool John Moores University (LJMU) are aiming to understand chronic pain experiences in and out of the UK’s current lockdown. Individuals are invited to participate in the survey.

Title of Project: Locked-down: Differences in Chronic Pain Experience
Researcher: Dr David Moore and Bethany Donaghy, School of Psychology

The study will take 20 minutes to complete and will involve completing a set of questionnaires online via outlets such as computers or mobile phones. There will also be the option to participate in a second phase of the study.…

Read more of this article

State of health and care: The NHS Long Term Plan after COVID-19

State of Health reportState of health and care: The NHS Long Term Plan after COVID-19

A new report from IPPR shows the extent to which the coronavirus pandemic has disrupted progress on the NHS Long Term Plan. The report looks at cancer, mental illness, cardiovascular disease and multiple long term conditions, but the findings are equally relevant to MSK services.

The report argues that COVID-19 should not become an excuse for low ambition, and that world-class healthcare must remain the overall goal. To achieve this, the report recommends a package of six ambitious changes designed to do three things:

  • Ensure the pandemic does not cause lasting damage to healthcare services for future generations.
…

Read more of this article

Survey findings from NRAS

Summary of article published in Rheumatology Advances in Practice on 5 January, 2021

“Disease impact of rheumatoid arthritis in patients not treated with advanced therapies; survey findings from the National Rheumatoid Arthritis Society”

Authors: Elena Nikiphorou, Hannah Jacklin, Ailsa Bosworth, Clare Jacklin, Patrick Kiely

Background

In 2020, NRAS conducted a survey amongst its members and non-members who had RA with a disease duration more than 2 years, who were not on advanced therapies (i.e. biologic/biosimilar or targeted synthetic DMARDs (JAK inhibitors)), with the aim of revealing the everyday impact of living with RA in people not treated with advanced therapies.…

Read more of this article

NHFD Annual Report

The challenge of the next decade: are hip fracture services ready?

The National hip Fracture Database (NHFD) has recently released its latest annual report focussing on the six NHFD key performance indicators used to monitor and drive up standards across the country. 2020 will no doubt prove to be one of the most challenging years in the history of the NHS. This report also presents the first data about the effect of COVID-19 on trauma units around the country and on outcome for patients with hip fracture who have COVID-19 when admitted to hospital or develop it after their operation.…

Read more of this article

RA disease not treated with advanced therapies

RA disease impact in patients not treated with advanced therapies; survey findings from the National Rheumatoid Arthritis Society

by NRAS

Recently NICE published a Final Appraisal Document in respect of a new JAK inhibitor (filgotinib –  Jyseleca) giving access to people with RA who have so called ‘moderate’ disease in addition to those with ‘severe’ disease. This is the first time NICE have broadened their eligibility criteria for access to advanced therapies and is warmly welcomed by NRAS. This comes at the same time as a paper published by the National Rheumatoid Arthritis Society (P.…

Read more of this article

Chronic Pain and the pandemic

Recently, Pain Alliance Europe conducted a 6-week short survey on Covid-19 and chronic pain in twelve languages to see the current situation of chronic pain patients in Europe.

The survey showed initial results that during the pandemic 15% of people worried and feared taking prescribed medication. There was also impact on self-management plans – of those people who had a plan, 29% indicate they are not able to continue with their care plan. From all countries, the respondents in the UK reported the highest impact of pain interfering with their normal functionality.…

Read more of this article

Assistive devices survey

The British Assistive Technology Association (BATA) has launched a survey, supported by the WHO’s GATE Programme (Global Cooperation on Assistive Technology), called the UK Priority Assistive Products List National Survey.

It is a survey about the most essential assistive products for people, aiming to create a list similar to the essential medicines list from WHO, of essential assistive devices. This is to help identify priorities of need and improve access for those who require an assistive device.

There are a number of categories, one is mobility.…

Read more of this article

Chronic pain in adults 2017: Health Survey for England

A new report from Public Health England examines data on chronic pain in England and analyses inequalities in the experience of chronic pain. The report will be useful for those commissioning and delivering services for those experiencing chronic pain and policy makers in central and local government. The findings on inequalities include that chronic pain is more prevalent in women than men; in people from the Black ethnic group than other ethnicities; and in those in more deprived areas.

The Global Burden of Disease Study 2016 has highlighted pain as one of the most prominent causes of disability worldwide.…

Read more of this article